Prediction of stereotactic body radiotherapy for liver tumor using hypoxia imaging
Phase 2
- Conditions
- liver tumors
- Registration Number
- JPRN-UMIN000030279
- Lead Sponsor
- Kindai University Faculty of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1. pregnancy or possible pregnancy 2. existence of severe systematic disease 3. Child-Pugh C 4. medical history of radiotherapy for upper abdomen 5. other (physician's decision)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method two-year local control
- Secondary Outcome Measures
Name Time Method overall survival, progression-free survival, local progression-free survival (local control), failure pattern, rate of completion of the treatment, incidence of toxicity, incidence of severe toxicity, volume of focal liver radiation damage and association of radiation-doses, validation among images, treatment planning, and images of image-guided radiotherapy, validation of set-up, intra-fraction, and inter-fraction errors, optimization of radiotherapy to minimize radiation exposure in radiotherapy, evaluation of accuracy of radiotherapy, differences between primary and metastatic liver tumors